WuXi Biologics hits 6-week high on confidence in delivering FY26 guidance

WuXi Biologics (Cayman)

01/06/2026 04:51

** Shares of WuXi Biologics (Cayman) Inc 2269.HK climb 3.4% to HK$35.46, their highest level since April 22
** Stock on track for the biggest one-day pct gain since May 26 in the second rising session
** Chinese biologics discovery, development, and manufacturing group said it added 69 new projects in the January-April period, with 2/3 of the new projects coming from the U.S. and EU 
** Confident in delivering FY26 guidance and maintains its expectation of reported revenue growth of 13%–17% y/y for the year, and the company initiated a new $400 million share repurchase program - co 
** YTD, stock up 8.9%, while Hang Seng Biotech Index .HSBIO down 6.2%
     
     
     

(Reporting by Donny Kwok)
((donny.kwok@thomsonreuters.com))